RECLAIM: Retrospective Evaluation of Clinical and Radiographic Outcomes Following Total Talus Replacement
Study Details
Study Description
Brief Summary
This study is a retrospective analysis of patients who underwent surgery using a total talus replacement (TTR) implant with or without concurrent total ankle replacement and/or subtalar fusion. This study seeks to analyze the clinical and radiographic outcomes of TTR implant recipients and generate additional data on the safety and benefit of the TTR implant.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Total Talus Replacement
|
Procedure: Total Talus Replacement (TTR)
Surgical implantation of restor3d's patient-specific custom Total Talus Replacement device.
|
Total Ankle Total Talus Replacement
|
Procedure: Total Ankle Total Talus Replacement (TATTR)
Surgical implantation of restor3d's patient-specific custom Total Ankle Total Talus Replacement (TATTR) device.
|
Total Ankle Total Talus Replacement + Subtalar Fusion
|
Procedure: Total Ankle Total Talus Replacement + Subtalar Fusion (TATTR + STJ)
Surgical implantation of restor3d's patient-specific custom Total Ankle Total Talus Replacement (TATTR) device with concurrent subtalar fusion.
|
Total Talus Replacement + Subtalar Fusion
|
Procedure: Total Talus Replacement + Subtalar Fusion (TTR + STJ)
Surgical implantation of restor3d's patient-specific custom Total Talus Replacement (TTR) device with concurrent subtalar fusion.
|
Outcome Measures
Primary Outcome Measures
- Improvement in pain from pre-operative baseline [12-months]
Primary probable benefit endpoint is improvement in pain at 12 months from preoperative baseline.
Secondary Outcome Measures
- Improvement in Patient Reported Outcomes [3 months]
Secondary probably benefit endpoints will include patient reported functional outcome measures
- Improvement in Patient Reported Outcomes [6 months]
Secondary probably benefit endpoints will include patient reported functional outcome measures
- Improvement in Patient Reported Outcomes [12 months]
Secondary probably benefit endpoints will include patient reported functional outcome measures
- Improvement in Patient Reported Outcomes [24 months]
Secondary probably benefit endpoints will include patient reported functional outcome measures
- Improvement in Patient Reported Outcomes [36 months]
Secondary probably benefit endpoints will include patient reported functional outcome measures
Other Outcome Measures
- Subsequent Surgical Intervention [Up to 3 years.]
The primary safety outcome measure is rate of subsequent surgical intervention (SSI), as defined as any surgical procedure or service required after the initial implant of the TTR device.
- Adverse Events (AEs)/Serious Adverse Events (SAEs) [Up to 3 years.]
Safety outcome measures by occurrence of adverse events (AEs), device- or procedure related AEs, and serious AEs.
Eligibility Criteria
Criteria
Inclusion Criteria:
-
18 Years of Age
-
Patient underwent surgery involving a total talus replacement implant between 1/1/2019 and 01/28/2022.
Exclusion Criteria:
- No available postoperative data
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Phoenix Foot and Ankle Institute | Phoenix | Arizona | United States | 85251 |
2 | Orthopaedic Institute of Western Kentucky | Paducah | Kentucky | United States | 42001 |
3 | The Bellevue Hospital | Bellevue | Ohio | United States | 44811 |
Sponsors and Collaborators
- Restor3D
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- restor3d-002